Author | Lyndsay J. Willmott, MD | OncLive

Author | Lyndsay J. Willmott, MD

Articles

Dr. Willmott on Mechanisms of Resistance in Ovarian Cancer

April 16, 2018

Video

Lyndsay J. Willmott, MD, gynecologic oncologist, Arizona Oncology, discusses the mechanisms of resistance to PARP inhibitors that have been identified in ovarian cancer.

Dr. Willmott on FDA Approval of Maintenance Olaparib in Ovarian Cancer

August 17, 2017

Video

Lyndsay J. Willmott, MD, a gynecologic oncologist with Arizona Oncology, discusses the FDA approval of olaparib (Lynparza) in the maintenance setting for relapsed patients with platinum-sensitive ovarian cancer.

x